MARKET NEWS

Albireo Pharma Announces New Phase 3 Data That Shows Durable Response to Odevixibat in a Rare Pediatric Liver Disease
Beam Therapeutics Presents First Data Highlighting Base Editing Program for Glycogen Storage Disease Type Ia
Cambrex to Invest $50 Million to Expand Multipurpose Large-Scale Manufacturing Capabilities in the US
CalciMedica Announces Publication of Preclinical Data Demonstrating the Pathological Role of Microglial CRAC Channels in Ischemic Stroke
BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial
Apellis Announces FDA Acceptance & Priority Review of NDA

  FEATURED EDITORIAL

  COMPANY PROFILE

If you’re looking for an automation partner who understands the precision and care required to manufacture the world’s finest drug delivery devices, consider Kahle Automation, Engineering Perfection since 1920. Kahle is the only large-scale automation company in the world that focuses exclusively on custom automated assembly equipment for medical and pharmaceutical devices. For nearly a century, Kahle has shaped the industry through the use of innovative technologies and we bring this experience to your project. Today, we create systems that handle, assemble, inspect, test and package every medical device imaginable – from syringes, tubing sets and catheters and needle products to diagnostic, pre-filled and combination pharmaceutical devices. Click here for more.

  EXCLUSIVE ONLINE CONTENT

WHITE PAPER ALERT - Considerations in Support of Achieving Successful Double Blinding and Removing Bias With Over Encapsulation

WHITE PAPER ALERT - Considerations in Support of Achieving Successful Double Blinding and Removing Bias With Over Encapsulation

Despite the relative simplicity of over-encapsulation, proper planning, and careful execution are still fundamental to success — full consideration must be given to every detail from capsule color and size selection to having a well-trained team dedicated to the process…..

Samsung Biologics Announces Strategic Manufacturing Partnership With Lilly to Accelerate Delivery of COVID-19 Antibody Treatments

Samsung Biologics Announces Strategic Manufacturing Partnership With Lilly to Accelerate Delivery of COVID-19 Antibody Treatments

Samsung Biologics’ partnership with Eli Lilly and Company is expected to greatly accelerate the global supply for Lilly’s COVID-19 antibody therapies through a long-term manufacturing agreement….

Assembly Biosciences & Door Pharmaceuticals Sign Collaboration & Option Agreement

Assembly Biosciences & Door Pharmaceuticals Sign Collaboration & Option Agreement

Assembly Biosciences, Inc. and Door Pharmaceuticals, LLC recently announced the companies have signed an exclusive, 2-year collaboration and option agreement focused on the development of….

XOMA Earns -Million Milestone From Takeda

XOMA Earns $2-Million Milestone From Takeda

XOMA Corporation recently announced it has earned a $2-million milestone payment from Takeda Pharmaceutical Company Limited as the first patient has been dosed….

Aeterna Zentaris Amends License Agreement With Novo Nordisk 

Aeterna Zentaris Amends License Agreement With Novo Nordisk 

Aeterna Zentaris Inc. recently announced that, through a wholly owned subsdiary, it has entered into an amendment of its existing License Agreement with Novo Nordisk Biopharm….

Evaluation Kit for Sensirion’s Single-Use Liquid Flow Sensor LD20-2600B is Now Available for Distribution

Evaluation Kit for Sensirion’s Single-Use Liquid Flow Sensor LD20-2600B is Now Available for Distribution

The LD20-2600B single-use liquid flow sensor for fast, precise and reliable measurements of the lowest flow rates in biomedical applications was successfully launched….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

December 2 – Formulation Development
December 9 – Drug Delivery